Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Clinical and prognostic implications of phenomapping in patients with heart failure receiving cardiac resynchronization therapy

Abstract : Background. - Despite having an indication for cardiac resynchronization therapy according to current guidelines, patients with heart failure with reduced ejection fraction who receive cardiac resynchronization therapy do not consistently derive benefit from it. Aim. - To determine whether unsupervised clustering analysis (phenomapping) can identify distinct phenogroups of patients with differential outcomes among cardiac resynchronization therapy recipients from routine clinical practice. Methods. - We used unsupervised hierarchical cluster analysis of phenotypic data after data reduction (55 clinical, biological and echocardiographic variables) to define new phenogroups among 328 patients with heart failure with reduced ejection fraction from routine clinical practice enrolled before cardiac resynchronization therapy. Clinical outcomes and cardiac resynchronization therapy response rate were studied according to phenogroups. Results. - Although all patients met the recommended criteria for cardiac resynchronization therapy implantation, phenomapping analysis classified study participants into four phenogroups that differed distinctively in clinical, biological, electrocardiographic and echocardiographic characteristics and outcomes. Patients from phenogroups 1 and 2 had the most improved outcome in terms of mortality, associated with cardiac resynchronization therapy response rates of 81% and 78%, respectively. In contrast, patients from phenogroups 3 and 4 had cardiac resynchronization therapy response rates of 39% and 59%, respectively, and the worst outcome, with a considerably increased risk of mortality compared with patients from phenogroup 1 (hazard ratio 3.23, 95% confidence interval 1.9-5.5 and hazard ratio 2.49, 95% confidence interval 1.38-4.50, respectively). Conclusions. - Among patients with heart failure with reduced ejection fraction with an indication for cardiac resynchronization therapy from routine clinical practice, phenomapping identifies subgroups of patients with differential clinical, biological and echocardiographic features strongly linked to divergent outcomes and responses to cardiac resynchronization therapy. This approach may help to identify patients who will derive most benefit from cardiac resynchronization therapy in ``individualized'' clinical practice. (c) 2020 Elsevier Masson SAS. All rights reserved.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-u-picardie.archives-ouvertes.fr/hal-03579645
Contributeur : Louise DESSAIVRE Connectez-vous pour contacter le contributeur
Soumis le : vendredi 18 février 2022 - 11:00:13
Dernière modification le : vendredi 5 août 2022 - 11:25:24

Lien texte intégral

Identifiants

Collections

Citation

Clemence Riolet, Aymeric Menet, Stephane Verdun, Alexandre Altes, Ludovic Appert, et al.. Clinical and prognostic implications of phenomapping in patients with heart failure receiving cardiac resynchronization therapy. Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2021, 114 (3), pp.197-210. ⟨10.1016/j.acvd.2020.07.004⟩. ⟨hal-03579645⟩

Partager

Métriques

Consultations de la notice

22